foxo4-dri peptide mechanism of action Molecular modelling the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells FOXO4-DRI PEPTIDE 2MG/5MG/10MG VIAL –
FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $7.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




